Pivot Pharmaceuticals Inc., formerly Neurokine Pharmaceuticals Inc., is a development-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic pharmaceutical products. The Company offers products for women's health and neurological targets. For women's health, the Company's product pipeline includes P-001, which is used for the treatment of dysmenorrhea, lower urinary tract symptoms and kidney stones; P-002, which is used for the treatment of peri-menopausal hot flushes, and P-003, which is used for the prevention and treatment of migraine headaches and the progression from mild cognitive impairment to dementia (Alzheimer's Disease progression). For neurological, the Company offers NK-001, which is used for the treatment of neurocognitive impairment in post-coronary artery bypass graft (CABG or heart bypass) surgery patients, and NK-002, a development-stage drug used for the treatment of Alzheimer's disease.